2013
DOI: 10.1111/hepr.12143
|View full text |Cite
|
Sign up to set email alerts
|

Carvedilol improves ethanol‐induced liver injury via modifying the interaction between oxidative stress and sympathetic hyperactivity in rats

Abstract: Carvedilol may modify the interaction between the oxidative stress and the sympathetic hyperactivity, and then contribute to attenuating the development of AFLD in rats. Additionally, oxidative stress may be responsible for the activation of HSC during the early stage of alcoholic liver disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 45 publications
1
8
0
Order By: Relevance
“…In accordance, our findings suggest that familial DCM hiPSC‐CMs have increased susceptibility to apoptosis and cell death after exposure to external chronotropic stress, and that pharmacological pretreatment with carvedilol or verapamil modestly reduced chronotropic stress‐induced apoptosis and cell death rate in familial DCM hiPSC‐CMs. In addition to negating inotropic and chronotropic actions, carvedilol also participates in antioxidant responses by mediating oxidative stress . Supplementary studies of the role of oxidative stress and carvedilol in RBM20 hiPSC‐CMs could be informative in modifying apoptotic response and disease progression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In accordance, our findings suggest that familial DCM hiPSC‐CMs have increased susceptibility to apoptosis and cell death after exposure to external chronotropic stress, and that pharmacological pretreatment with carvedilol or verapamil modestly reduced chronotropic stress‐induced apoptosis and cell death rate in familial DCM hiPSC‐CMs. In addition to negating inotropic and chronotropic actions, carvedilol also participates in antioxidant responses by mediating oxidative stress . Supplementary studies of the role of oxidative stress and carvedilol in RBM20 hiPSC‐CMs could be informative in modifying apoptotic response and disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to negating inotropic and chronotropic actions, carvedilol also participates in antioxidant responses by mediating oxidative stress. 45,46 Supplementary studies of the role of oxidative stress and carvedilol in RBM20 hiPSC-CMs could be informative in modifying apoptotic response and disease progression.…”
Section: Discussionmentioning
confidence: 99%
“…Carvedilol has been reported to be effective in various ROS-related tissue injury models (Huang et al, 2007;Rodrigues et al, 2011;Saeidnia & Abdollahi;Singh et al, 2004) such as alcoholic fatty liver disease, hepatic IR, insulin sensitivity, and sympathetic hyperactivity in rats, which can be of great interest as there is a close association between PCOS and above-mentioned disorders (Bhatt et al, 2007;Hakucho et al, 2014;Kveiborg et al, 2006). Supporting our results, administration of carvedilol also had a beneficial effect on the bone quality in ovariectomized postmenopausal rat model via estradiol enhancement, antioxidants promotion, and diminishing in resorbing TNF-a and IL-6 (Boshra & El Wakeel, 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Carvedilol, another non-selective β-receptor antagonist, has been used in an animal model of alcoholic fatty liver disease and was found to attenuate oxidative stresses caused by the hypermetabolic state [140]. Given that non-selective beta-blockade appears to affect ER stress in both burn and alcohol exposures, administration in the setting of combined injury should also help prevent associated oxidative damage and the development of steatosis.…”
Section: Clinical Managementmentioning
confidence: 99%